semaglutide trapped gas How to Manage Side Effects? 5 Easy Tips How to Get Rid of

Description

A 2024 retrospective chart review found that 67% of IBS-D (diarrhea-predominant) patients using GLP-1 medications reported moderate to significant symptom improvement within 812 weeks of starting treatment

doi: 10.3390/ijms25031493

Lancet Diabetes Endocrinol 2025;13:374383 [DOI] [PMC free article] [PubMed] [Google Scholar] 300

Note dose, timing, and symptoms for a week

Published online January 26, 2024 DOI: 15,652 View 850 Download 11 Web of Science 9 Crossref Abstract PDFSupplementary MaterialPubReader ePub Background We investigated the long-term efficacy and safety of initial triple therapy using metformin, a dipeptidyl peptidase-4 inhibitor, and a sodium-glucose cotransporter-2 inhibitor, in patients with type 2 diabetes mellitus